COUMADIN Safety Questions, COUMADIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about COUMADIN. Our extensive database of COUMADIN adverse events and COUMADIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about COUMADIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




COUMADIN Safety Reports

Total COUMADIN reports: 784.
COUMADIN FDA safety alerts: 2002 2005 2006 2007 .
Reported deaths: 105    Reported hospitalizations: 270.
Take COUMADIN Side Effects Survey or Share Your COUMADIN Story. COUMADIN Usage.

Showing 1-75 of 784 Next >

Health Professional from FRANCE reported COUMADIN problem on Feb 28, 2007. Female patient, 47 years of age, weighting 138.9 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: lymphopenia, necrosis, vascular purpura. COUMADIN dosage: unknown. During the same period patient was treated with PREVISCAN. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Health Professional from FRANCE on Feb 28, 2007. Male patient, 56 years of age, was diagnosed with prophylaxis, pulmonary tuberculosis, sleep disorder and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: porphyria. COUMADIN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, DEXAMBUTOL, ZOLPIDEM TARTRATE, RIFATER. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on Mar 02, 2007. Male patient, 89 years of age, weighting 126.3 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, chest pain, diarrhoea, dyspnoea, gastrointestinal haemorrhage, international normalised ratio increased, prothrombin time prolonged, pyrexia. COUMADIN dosage: 1 MG ON EVEN DAYS, 2MG ODD DAYS DAILY PO. During the same period patient was treated with PLAVIX, ZANTAC, SINGULAIR, SEREVENT, LISINOPRIL, METOPROLOL SUCCINATE, ASPIRIN, PREDNISONE. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Pharmacist from UNITED STATES on Mar 02, 2007. Male patient, 69 years of age, weighting 178.6 lb, was diagnosed with pulmonary embolism and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haematoma, international normalised ratio increased, prothrombin time prolonged. COUMADIN dosage: 5MG DAILY PO. During the same period patient was treated with PREDNISONE, NORVASC, HYDROCHLOROTHIAZIDE, BENICAR, ADVAIR DISKUS, PROZAC, PROTONIX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 02, 2007. Female patient, 70 years of age, weighting 132.3 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: chromosome abnormality, platelet disorder. COUMADIN dosage: unknown. During the same period patient was treated with FIORINAL, ASPIRIN. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 23, 2007. Female patient, 52 years of age, weighting 220.0 lb, was diagnosed with thrombosis prophylaxis, gout and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal wall infection, abscess, adhesiolysis, alveoloplasty, back pain, bacterial infection, bone disorder, bone neoplasm malignant, cardiac failure congestive. COUMADIN dosage: 7.5 MG, QD. During the same period patient was treated with ALLOPURINOL, POTASSIUM ACETATE, PROTONIX, ALDACTONE, ALPRAZOLAM, FERROUS SULPHATE, INTERFERON. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on Mar 06, 2007. Female patient, 82 years of age, weighting 228.0 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: blister, contusion, haemorrhagic anaemia, hypotension, limb injury, necrosis, pain in extremity. COUMADIN dosage: 10MG PO DAILY. During the same period patient was treated with LOVENOX, LISINOPRIL, LOMOTIL, SYNTHROID, LASIX, ATENOLOL, ATIVAN, CYMBALTA. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Health Professional from UNITED STATES on Mar 06, 2007. Male patient, 86 years of age, weighting 222.7 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: hospitalisation. COUMADIN dosage: unknown. During the same period patient was treated with CANGRELOR, CLOPIDOGREL BISULPHATE, LOVENOX. Patient was hospitalized. Patient recovered.

Health Professional from ITALY reported COUMADIN problem on Mar 08, 2007. Male patient, 86 years of age, was diagnosed with arrhythmia and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: bladder diverticulum, blood pressure increased, haematuria, international normalised ratio increased, nephrolithiasis, neuropathy peripheral, renal cyst. COUMADIN dosage: unknown. Patient recovered.

COUMADIN problem was reported by a Physician from UNITED STATES on Mar 07, 2007. Male patient, 88 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, pneumonia aspiration. COUMADIN dosage: unknown. Patient died on 10/10/2006.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 14, 2007. Male patient, 85 years of age, weighting 149.9 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: dizziness, fall, gait disturbance, injury, international normalised ratio fluctuation, stomach discomfort. COUMADIN dosage: 2.5MG/D ALTERNATING WITH 5MG/D. During the same period patient was treated with NIFEDIPINE, ATENOLOL, DIOVAN, PROSCAR, HYTRIN, CLONAZEPAM, MYSOLINE. Patient recovered.

COUMADIN problem was reported by a Physician from UNITED STATES on Mar 14, 2007. Male patient was diagnosed with cardiac valve disease and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cardiac valve disease, coronary artery disease. COUMADIN dosage: ALTERNATING DOSES 2MG AND 5MG. Patient died.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 15, 2007. Male patient, 85 years of age, weighting 149.9 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: dizziness, fall, international normalised ratio fluctuation, stomach discomfort. COUMADIN dosage: 2.5MG/D ALTERNATING WITH 5MG/D. During the same period patient was treated with NIFEDIPINE, ATENOLOL, DIOVAN, PROSCAR, HYTRIN, CLONAZEPAM, MYSOLINE. Patient recovered.

COUMADIN problem was reported by a Health Professional from UNITED STATES on Mar 19, 2007. Female patient, child 10 years of age, was diagnosed with anaemia, respiratory failure and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: pneumonia, renal failure. COUMADIN dosage: unknown. During the same period patient was treated with PROCRIT, OXYGEN, INSULIN. Patient was hospitalized. Patient died on 01/23/2007.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 20, 2007. Male patient, 76 years of age, weighting 180.8 lb, was diagnosed with atrial fibrillation, musculoskeletal pain and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, chronic obstructive pulmonary disease. COUMADIN dosage: unknown. During the same period patient was treated with COLCHICINE, LIPITOR, LASIX, HYDROCHLOROTHIAZIDE, SPIRIVA, LORTAB, PREDNISONE, ALBUTEROL. Patient was hospitalized. Patient died on 03/14/2007.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2007. Male patient, 58 years of age, was treated with COUMADIN. COUMADIN dosage: unknown. Patient died.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 12, 2007. Female patient was diagnosed with insomnia and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: confusional state, fall, haemorrhage intracranial, sleep walking. COUMADIN dosage: unknown. During the same period patient was treated with AMBIEN. Patient died on 02/23/2006.

COUMADIN problem was reported by a Health Professional from UNITED STATES on Mar 21, 2007. Female patient, 66 years of age, weighting 154.0 lb, was diagnosed with hypercoagulation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. COUMADIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on Mar 22, 2007. Female patient, 73 years of age, weighting 129.2 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, fall, haemorrhage, international normalised ratio increased, mouth injury. COUMADIN dosage: 5 MG DAILY PO. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Health Professional from FRANCE on Mar 22, 2007. Male patient, 84 years of age, was diagnosed with embolism, thrombosis, epilepsy and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: epistaxis. COUMADIN dosage: unknown. During the same period patient was treated with KARDEGIC, SEROPRAM, NEURONTIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 22, 2007. Male patient, 83 years of age, weighting 262.4 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased, thrombosis, transient ischaemic attack. COUMADIN dosage: 11-06-02-07 DOSE=1MGX4D/WK .5 MGX3D/WK 02-07 6 MG/WK INCREASED 03-15-07 7MG/WK 03-22-07 8.5 MG/WK. During the same period patient was treated with PLAVIX, DIGITEK, VYTORIN, SYNTHROID, TYLENOL, TRIAMTERENE, AVODART, TOPROL. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2007. Female patient, 80 years of age, weighting 163.1 lb, was diagnosed with arrhythmia and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: burning sensation, epistaxis, insomnia, oedema peripheral, pain in extremity. COUMADIN dosage: 4 MG TAB 3 TIMES/WK AND 2 MG REMAINING DAYS; THEN 4 MG TWICE/WK AND 2 MG REMAINING DAYS. During the same period patient was treated with PLAVIX, TOPROL, ASPIRIN, TYLENOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 27, 2007. Male patient, weighting 253.5 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, coagulopathy, deep vein thrombosis, pulmonary embolism. COUMADIN dosage: unknown. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2007. Male patient, 74 years of age, weighting 189.6 lb, was diagnosed with cardiac disorder and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: bronchitis, haemoptysis. COUMADIN dosage: unknown. During the same period patient was treated with FUROSEMIDE, METOPROLOL SUCCINATE, FINASTERIDE, SIMVASTATIN, TAMSULOSIN, ASPIRIN, POTASSIUM CHLORIDE, COMBIVENT. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported COUMADIN problem on Apr 05, 2007. Female patient, 42 years of age, weighting 134.5 lb, was diagnosed with deep vein thrombosis, breast cancer metastatic and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: epistaxis, international normalised ratio increased, prothrombin time prolonged, sinusitis. COUMADIN dosage: unknown. During the same period patient was treated with LAPATINIB, CAPECITABINE. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient, weighting 143.3 lb, was diagnosed with transient ischaemic attack and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, flatulence, transient ischaemic attack. COUMADIN dosage: unknown. During the same period patient was treated with DYAZIDE, TENORMIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on Apr 05, 2007. Male patient, 81 years of age, weighting 191.0 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: aspiration, cerebral haemorrhage, headache, hypoxia, nausea, vomiting. COUMADIN dosage: 1.5MG AS DIRECTED ORALLY. During the same period patient was treated with CYANOCOBALAMIN, LISINOPRIL, OMEPRAZOLE, SIMVASTATIN. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Male patient, 83 years of age, was diagnosed with osteoporosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: arrhythmia, asthenia, cholelithiasis, gait disturbance, gallbladder disorder, jaundice. COUMADIN dosage: 5 MG, DAILY (1/D) MONDAY THROUGH FRIDAY. During the same period patient was treated with FORTEO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Apr 10, 2007. Female patient, weighting 138.9 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased, lymphoma. COUMADIN dosage: unknown. During the same period patient was treated with LISINOPRIL, CARDIZEM, DIGITEK, LEXAPRO, ASCORBIC ACID, CALCIUM LACTATE, CANSTAT, PROTEASE. Patient recovered.

COUMADIN problem was reported by a Health Professional from UNITED STATES on Apr 10, 2007. Male patient, weighting 235.0 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, international normalised ratio decreased. COUMADIN dosage: 5 MG ONCE A DAY PO. Patient died on 03/17/2007.

Health Professional from FRANCE reported COUMADIN problem on Apr 16, 2007. Female patient, 55 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage. COUMADIN dosage: unknown. During the same period patient was treated with AVASTIN, CAMPTOSAR, FLUOROURACIL, ZOPHREN. Patient died on 01/25/2007.

COUMADIN problem was reported by a Health Professional from FRANCE on Apr 16, 2007. Female patient, 81 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. COUMADIN dosage: unknown. During the same period patient was treated with OMEPRAZOLE, INNOHEP, ACETAMINOPHEN AND TRAMADOL, LOVENOX, ORGARAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Apr 13, 2007. Female patient, 78 years of age, weighting 134.5 lb, was diagnosed with transient ischaemic attack and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, international normalised ratio decreased, skin discolouration, transient ischaemic attack. COUMADIN dosage: unknown. During the same period patient was treated with PLAVIX, ASPIRIN, PROGESTERONE, ESTRADERM, DIGOXIN. Patient recovered.

COUMADIN problem was reported by a Pharmacist from UNITED STATES on Apr 19, 2007. Male patient, 78 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, post procedural haemorrhage, ventricular arrhythmia. COUMADIN dosage: unknown. During the same period patient was treated with LOVENOX. Patient died.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Apr 18, 2007. Female patient, 78 years of age, weighting 134.5 lb, was diagnosed with transient ischaemic attack and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, international normalised ratio decreased, skin discolouration, transient ischaemic attack. COUMADIN dosage: unknown. During the same period patient was treated with PLAVIX, ASPIRIN, PROGESTERONE, ESTRADERM, DIGOXIN. Patient recovered.

COUMADIN problem was reported by a Pharmacist from UNITED STATES on Apr 20, 2007. Male patient, 73 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal haematoma, confusional state, haematocrit decreased, haemoglobin decreased, retroperitoneal haemorrhage. COUMADIN dosage: unknown. During the same period patient was treated with LOVENOX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Apr 20, 2007. Female patient, 22 years of age, weighting 127.9 lb, was diagnosed with pulmonary embolism and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: dehydration, dyspnoea, haemoptysis, international normalised ratio decreased, nausea, vomiting. COUMADIN dosage: unknown. During the same period patient was treated with HEPARIN, LOVENOX, PEPCID, FOLIC ACID, PHENERGAN, DILAUDID. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Physician from FRANCE on Apr 17, 2007. Female patient, weighting 130.1 lb, was diagnosed with ill-defined disorder, hypertension and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: confusional state. COUMADIN dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE. Patient recovered.

Health Professional from FRANCE reported COUMADIN problem on Apr 23, 2007. Male patient, 63 years of age, weighting 198.4 lb, was diagnosed with pulmonary embolism, phlebitis, hypercholesterolaemia, gastric ulcer, hypertension and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage intracranial, road traffic accident. COUMADIN dosage: unknown. During the same period patient was treated with ALLOPURINOL, FENOFIBRATE, NEXIUM, INDAPAMIDE, CALDINE. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 25, 2007. Male patient, weighting 132.3 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. COUMADIN dosage: unknown. Patient was hospitalized and became disabled. Patient died.

Pharmacist from UNITED STATES reported COUMADIN problem on Apr 25, 2007. Female patient was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased. COUMADIN dosage: 10MG DAILY PO. Patient recovered.

COUMADIN problem was reported by a Health Professional from FRANCE on Apr 25, 2007. Female patient, 65 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: gastric ulcer haemorrhage, international normalised ratio increased. COUMADIN dosage: unknown. During the same period patient was treated with PERISTALTINE, FORLAX, CONTRAMAL, TRACLEER, PARACETAMOL, DIFFU, INIPOMP, LOVENOX. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on Apr 26, 2007. Female patient, 91 years of age, weighting 75.18 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haematoma. COUMADIN dosage: 1 MG DAILY PO. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 27, 2007. Male patient, 81 years of age, weighting 240.3 lb, was diagnosed with thrombosis prophylaxis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: anuria, asthenia, contusion, thrombosis, vision blurred. COUMADIN dosage: unknown. During the same period patient was treated with AMIODARONE, DIGITALIS, OCUVITE, LIPITOR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on May 01, 2007. Male patient, 75 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: fall, international normalised ratio fluctuation. COUMADIN dosage: unknown. During the same period patient was treated with DILTIAZEM, ZETIA, TEMODAR, PROTONIX, MUCOMYST, LEVEMIR, KEPPRA, DILANTIN. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Pharmacist from UNITED STATES on May 02, 2007. Female patient, weighting 221.6 lb, was diagnosed with atrial fibrillation, cellulitis, staphylococcal infection and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased, small intestinal haemorrhage, vomiting. COUMADIN dosage: unknown. During the same period patient was treated with BACTRIM DS, BACTRIM DS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported COUMADIN problem on May 03, 2007. Female patient, 87 years of age, weighting 118.0 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: coagulopathy, ecchymosis, epistaxis, haematochezia, haemoptysis, haemorrhage. COUMADIN dosage: 7 MG 3 X A WEEK PO. During the same period patient was treated with GINGER. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Male patient, 42 years of age, weighting 253.5 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, coagulopathy, deep vein thrombosis, pulmonary embolism. COUMADIN dosage: DOSE 20MG 31MAR07, ALSO GIVEN 60 MG 28MAR07, 30MG 1APR07, 50MG 3APR-5APR07. During the same period patient was treated with ADVAIR DISKUS, ALBUTEROL, ASPIRIN, DIAZEPAM, METOPROLOL SUCCINATE, ATORVASTATIN CALCIUM, MEPERIDINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on May 08, 2007. Female patient, weighting 119.0 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, cerebral atrophy. COUMADIN dosage: unknown. During the same period patient was treated with LOVASTATIN, METOPROLOL SUCCINATE, HYZAAR, DIGITEK, POTASSIUM ACETATE, OMEPRAZOLE, PREMARIN. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Male patient, 92 years of age, was diagnosed with ejection fraction decreased, discomfort and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cardiac output decreased, cardiogenic shock. COUMADIN dosage: WARFARIN 1MG ALSO MENTIONED. During the same period patient was treated with MORPHINE, PHENERGAN, ATIVAN. Patient died on 12/13/2006.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on May 08, 2007. Male patient, 92 years of age, was diagnosed with ejection fraction decreased, discomfort and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cardiac output decreased, cardiogenic shock. COUMADIN dosage: WARFARIN 1MG ALSO MENTIONED. During the same period patient was treated with MORPHINE, PHENERGAN, ATIVAN. Patient died on 12/13/2006.

COUMADIN problem was reported by a Health Professional from FRANCE on May 09, 2007. Female patient, 62 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: bradycardia, subdural haematoma. COUMADIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on May 16, 2007. Female patient, 80 years of age, weighting 169.8 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, rectal haemorrhage. COUMADIN dosage: unknown. During the same period patient was treated with NORVASC, ZANTAC, TRAMADOL, GLUCOSAMINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Pharmacist from UNITED STATES on May 16, 2007. Male patient, 76 years of age, weighting 238.1 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: arteriovenous malformation, asthenia, colonic polyp, dyspnoea, haematocrit decreased, haemoglobin decreased, hypotension, international normalised ratio increased, occult blood positive. COUMADIN dosage: unknown. During the same period patient was treated with TOPROL, ASPIRIN, FUROSEMIDE, POTASSIUM CHLORIDE, DILTIAZEM CD, GLIPIZIDE, LISINOPRIL, LIPITOR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on May 08, 2007. Female patient, 80 years of age, weighting 127.0 lb, was diagnosed with osteoporosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: balance disorder, fall, injury, subdural haematoma. COUMADIN dosage: unknown. During the same period patient was treated with LOVASTATIN, SYNTHROID, FORTEO. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2007. Female patient, 87 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, atrial fibrillation, dementia alzheimer's type, vaginal haemorrhage. COUMADIN dosage: unknown. Patient died on 05/05/2007.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on May 18, 2007. Female patient, 87 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, atrial fibrillation, dementia alzheimer's type, vaginal haemorrhage. COUMADIN dosage: unknown. Patient died on 05/05/2007.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Male patient, 68 years of age, was diagnosed with myocardial infarction, thrombosis and was treated with COUMADIN. COUMADIN dosage: unknown. Patient died on 10/31/1987.

Pharmacist from FRANCE reported COUMADIN problem on May 25, 2007. Female patient, 60 years of age, was diagnosed with factor v leiden mutation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, arterial thrombosis, colitis ischaemic, diarrhoea. COUMADIN dosage: unknown. During the same period patient was treated with KARDEGIC. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, weighting 169.8 lb, was treated with COUMADIN. COUMADIN dosage: unknown. During the same period patient was treated with NEURONTIN, EFFEXOR, CRESTOR, XOPENEX. Patient died on 05/25/2007.

Health Professional from FRANCE reported COUMADIN problem on May 28, 2007. Male patient, 81 years of age, weighting 167.6 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haematoma, lung disorder, neurological symptom. COUMADIN dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, MORPHINE CHLORIDE, RYTHMOL, DILTIAZEM, URAPIDIL. Patient died on 02/09/2007.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Male patient, 74 years of age, weighting 189.6 lb, was diagnosed with cardiac disorder and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: bronchitis, haemoptysis. COUMADIN dosage: unknown. During the same period patient was treated with FUROSEMIDE, METOPROLOL SUCCINATE, FINASTERIDE, SIMVASTATIN, TAMSULOSIN, ASPIRIN, POTASSIUM CHLORIDE, COMBIVENT. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported COUMADIN problem on May 31, 2007. Male patient, 78 years of age, was diagnosed with multiple myeloma and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: dehydration, gastrointestinal haemorrhage, prothrombin time prolonged, respiratory distress. COUMADIN dosage: unknown. During the same period patient was treated with REVLIMID. Patient was hospitalized. Patient died on 04/02/2007.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Female patient, 66 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: foaming at mouth, loss of consciousness. COUMADIN dosage: unknown. During the same period patient was treated with PLAVIX, ASPIRIN, COREG. Patient died on 04/21/2007.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on June 01, 2007. Female patient, 74 years of age, weighting 138.9 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased, lymphoma. COUMADIN dosage: unknown. During the same period patient was treated with LISINOPRIL, CARDIZEM, DIGITEK, LEXAPRO, ASCORBIC ACID, CALCIUM LACTATE, CANSTAT, PROTEASE. Patient recovered.

COUMADIN problem was reported by a Physician from FRANCE on June 11, 2007. Female patient, 81 years of age, was diagnosed with tuberculosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: biliary tract infection, dementia, hepatitis toxic, international normalised ratio increased, intervertebral discitis, lung disorder, overdose, peritonitis. COUMADIN dosage: unknown. During the same period patient was treated with RIFADIN, OFLOCET. Patient was hospitalized. Patient died.

Physician from FRANCE reported COUMADIN problem on June 11, 2007. Male patient, 95 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: coagulopathy, erysipelas. COUMADIN dosage: unknown. During the same period patient was treated with DOLIPRANE, PYOSTACINE, BURINEX, XATRAL, HEMIGOXINE NATIVELLE, CARBOSYLANE, METFORMIN. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Physician from FRANCE on June 11, 2007. Female patient, 84 years of age, weighting 79.37 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, pancreatic enzymes increased. COUMADIN dosage: unknown. During the same period patient was treated with LORAZEPAM, ATHYMIL, AMLOR, LAMICTAL, TAHOR, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on June 15, 2007. Male patient, 58 years of age, weighting 250.0 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: ecchymosis, extremity necrosis, pain in extremity. COUMADIN dosage: 5MG PO DAILY. During the same period patient was treated with LOPRESSOR, CRESTOR, ASPIRIN, PLAVIX, LORTAB. Patient recovered.

COUMADIN problem was reported by a Physician from ITALY on June 19, 2007. Female patient, 71 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: renal failure, shock, stomatitis. COUMADIN dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported COUMADIN problem on June 19, 2007. Female patient, 84 years of age, weighting 79.37 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. COUMADIN dosage: unknown. During the same period patient was treated with LORAZEPAM, ATHYMIL, AMLOR, LAMICTAL, TAHOR, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 18, 2007. Female patient, 64 years of age, weighting 220.0 lb, was diagnosed with deep vein thrombosis, pulmonary thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage, incorrect dose administered, skin laceration. COUMADIN dosage: unknown. During the same period patient was treated with LOVENOX, ENTERIC ASPIRIN. Patient died on 06/06/2007.

Physician from UNITED STATES reported COUMADIN problem on June 08, 2007. Male patient, 40 years of age, was diagnosed with vascular bypass graft, multiple congenital abnormalities and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease. COUMADIN dosage: unknown. During the same period patient was treated with PLAVIX. Patient recovered.

COUMADIN problem was reported by a Physician from ITALY on June 19, 2007. Female patient, 71 years of age, was diagnosed with atrial fibrillation, hyperuricaemia and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: renal failure, shock, stomatitis. COUMADIN dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on June 18, 2007. Female patient, 52 years of age, weighting 220.0 lb, was diagnosed with thrombosis prophylaxis, gout and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abscess, adhesiolysis, alveoloplasty, back pain, bacterial infection, bone disorder, bone neoplasm malignant, cardiac failure congestive, depressed level of consciousness. COUMADIN dosage: 7.5 MG, QD. During the same period patient was treated with ALLOPURINOL, POTASSIUM ACETATE, PROTONIX, ALDACTONE, ALPRAZOLAM, FERROUS SULPHATE, INTERFERON. Patient was hospitalized. Patient recovered.

Showing 1-75 of 784 Next >

Ask Our Patient Community about COUMADIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)